Zykadia-noxalk (150 mg)

NOVARTIS

“Zykadia” contains Drug / Molecule called “Ceritinib”. Zykadia is an anaplastic lymphoma kinase (ALK) positive inhibitor primarily used for the treatment of metastatic NSCLC. Zykadia thus acts to inhibit mutated enzyme and stop cell proliferation, ultimately halting cancer progression.

Category:

Indication

Zykadia is used for the treatment of non-small cell lung cancer.

Note

Precaution

  • Zykadia is a prescription drug and should be used under proper medical guidance and advice.
  • Zykadia may cause severe, life-threatening or fatal interstitial lung disease / pneumonitis.

Related products